GILD - Gilead gains on trial win for twice-yearly HIV PrEP therapy
2024-06-20 10:00:20 ET
More on Gilead Sciences
- Gilead Sciences, Inc. (GILD) Goldman Sachs 45th Annual Global Healthcare Conference (Transcript)
- Gilead Sciences, Inc. (GILD) Jefferies 2024 Global Healthcare Conference
- Gilead Sciences: Seriously Undervalued At Peak Pessimism
- EU to require additional cancer risk labeling on CAR T therapies
- Gilead spikes as Jefferies highlights weight loss prospects